“Zombie gene” protects elephants from cancer finds study

NewsGuard 100/100 Score

A new study has found that elephants do not get cancers as frequently as other animals because of a special gene that they carry.

Researchers led by Vincent J. Lynch, an evolutionary biologist at the University of Chicago said that their team found that the elephants carry this unique gene that can kill all the cells that have damaged DNA. Cells with mutated and altered or damaged DNA are ones that multiply to give rise to cancers. They noticed that with evolution, this helpful gene became dormant and in elephants alone a bit of this gene still remains functional. They call it the “zombie” gene that has been resurrected. The study appeared in the latest issue of the journal Cell Reports.

Image Credit: Willyam Bradberry / Shutterstock
Image Credit: Willyam Bradberry / Shutterstock

According to Lynch, deeper understanding of this phenomenon could help researchers find new drugs to fight cancer. He explained that it could help them understand cancer as a process and eventually how to combat it. Since the 1970’s the lack of cancers in these large animals has been studied extensively. Genetic studies to understand why this happens are a recent development.

Earlier, the p53 gene was the only candidate that was focussed upon. This gene – p53 makes a protein that can sense when a cell has a damaged DNA. The protein on detecting a cell with damaged DNA switches on several other genes.

This stimulates the cell to take two courses of action – either repair the damage or commit suicide to prevent the mutation from spreading to its progeny. Dr. Lynch and his colleagues a few years earlier found that elephants have unusual p53 genes.

Humans have a single copy of this gene but elephants seemed to have 20 copies of this gene. Same findings were seen independently by researchers at the University of Utah. Both teams noticed that these p53 genes respond with more aggression when there encounter a cell with damaged DNA. As soon as they encounter a cell with damaged DNA, they do not initiate a repair but go for cell death.

The study and search for these genes continued at Lynch’s lab till they found another gene. This is called the LIF6. This gene is found only in elephants. They found that when there was DNA damage, the p53 genes in the elephants switched on the LIF6. This gene makes LIF6 proteins. These proteins attack the cell’s mitochondria that provide energy to the cell for its functions. The mitochondrial walls are cut open by these proteins and their molecules leak out. These molecules from the mitochondria are toxic to the cell and end up killing the cell.

Researchers looked at the evolution of LIF6 and found that all mammals carry a similar gene called the LIF. These send out cell signals. However humans and other animals seemed to have a single copy of this gene. Elephants and their close evolutionary relatives like the manatees have several copies of this gene. Elephants were found to have 10 copies of this gene. These multiple copies arose due to mutations in the manatees’ and elephants’ ancestors around 80 million years ago they speculated. Thus the additional copies of the LIF genes in elephants and manatees are different from the original ones. They do not carry a bit of the DNA that acts as an on-off switch. This made these genes incapable of making LIF proteins. With time one of the ten LIF genes in the elephants that were dead came back to life like a zombie and regained its switch. This is called the LIF6 gene. Now this LIF6 gene with a switch could be activated by the p53 gene and initiate damaged cell killing.

Dr. Lynch said that ancestors of elephants developed extra copies of the p53 gene and at the same time resurrected the LIF6 gene causing them to be able to resist the cancers.

Reference: https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31145-8

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). “Zombie gene” protects elephants from cancer finds study. News-Medical. Retrieved on May 02, 2024 from https://www.news-medical.net/news/20180814/Zombie-gene-protects-elephants-from-cancer-finds-study.aspx.

  • MLA

    Mandal, Ananya. "“Zombie gene” protects elephants from cancer finds study". News-Medical. 02 May 2024. <https://www.news-medical.net/news/20180814/Zombie-gene-protects-elephants-from-cancer-finds-study.aspx>.

  • Chicago

    Mandal, Ananya. "“Zombie gene” protects elephants from cancer finds study". News-Medical. https://www.news-medical.net/news/20180814/Zombie-gene-protects-elephants-from-cancer-finds-study.aspx. (accessed May 02, 2024).

  • Harvard

    Mandal, Ananya. 2018. “Zombie gene” protects elephants from cancer finds study. News-Medical, viewed 02 May 2024, https://www.news-medical.net/news/20180814/Zombie-gene-protects-elephants-from-cancer-finds-study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact